12:00-12:05 p.m. EDT
|
Welcome and Introduction to Immunoprevention Virtual Summit
Leisha Emens, MD, PhD – Ankyra Therapeutics, SITC President Philip Castle, PhD, MPH – National Cancer Institute
|
12:05-12:20 p.m. EDT
|
Immunoprevention: Opportunities and Challenges Olivera Finn, PhD, FAIO – University of Pittsburgh
|
12:20-12:35 p.m. EDT
|
HPV Vaccines: A Model for Immunoprevention Douglas Lowy, MD – National Cancer Institute
|
12:35-12:50 p.m. EDT
|
Immune Interception of Pre-Malignancy Bernard Fox, PhD – Providence Cancer Institute, Earle A. Chiles Research Institute
|
12:50-1:05 p.m.. EDT
|
Immune Targets for Interception and Prevention Avrum Spira, MD, MSC – Johnson & Johnson, Boston University
|
1:05-1:20 p.m. EDT
|
Panel Discussion and Q&A Moderator: Sasha Stanton, MD, PhD – Providence Cancer Institute, Earle A. Chiles Research Institute Olivera Finn, PhD, FAIO – University of Pittsburgh Bernard Fox, PhD – Providence Cancer Institute, Earle A. Chiles Research Institute Douglas Lowy, MD – National Cancer Institute Avrum Spira, MD, MSC – Johnson & Johnson, Boston University
|
1:20-1:30 p.m. EDT
|
Break
|
1:30-2:10 p.m. EDT
|
Panel 1: Immune Microenvironment of Pre-Malignancy Moderator: Jerome Galon, PhD – INSERM, Sorbonne University Paris Steve Dubinett, MD – David Geffen School of Medicine at UCLA Nicolas Jacquelot, PhD – Arnie Charbonneau Cancer Institute, University of Calgary Kornelia Polyak, MD, PhD – Dana-Farber Cancer Institute
|
2:10-2:50 p.m. EDT
|
Panel 2: Immune Interception Strategies Moderator: Bernard Fox, PhD – Providence Cancer Institute, Earle A. Chiles Research Institute Irene Ghobrial, MD – Dana-Farber Cancer Institute Glenn Hanna, MD – Dana-Farber Cancer Institute Steven Lipkin, MD, PhD – Weill Cornell Medicine Neeha Zaidi, MD – Johns Hopkins Hospital
|
2:50-3:00 p.m. EDT
|
Break
|
3:00- 3:40 p.m. EDT
|
Panel 3: Primary Immunoprevention Strategies Moderator: Powel Brown, MD, PhD – MD Anderson Cancer Center Susan Domchek, MD – University of Pennsylvania Sasha Stanton, MD, PhD – Providence Cancer Institute, Earle A. Chiles Research Institute Eduardo Vilar-Sanchez, MD, PhD – MD Anderson Cancer Center Baochun Zhang, MD, PhD – Dana-Farber Cancer Institute
|
3:40-4:20 p.m. EDT
|
Panel 4: Clinical Trials: Patient Selection, Design, and Endpoints Moderator: Eva Szabo, MD – National Cancer Institute Mark Cobbold, MRCP, PhD – AstraZeneca Powel Brown, MD, PhD – MD Anderson Cancer Center Kevin Dodd, PhD – National Cancer Institute Steve Dubinett, MD – David Geffen School of Medicine at UCLA Virginia Mason, RN, BSN – Inflammatory Breast Cancer Research Foundation Jeffrey Roberts, MD – Merck Research Laboratories Sasha Stanton, MD, PhD – Providence Cancer Institute, Earle A. Chiles Research Institute
|
4:20-5:05 p.m. EDT
|
Panel 5: New and Existing NCI Resources for Immunoprevention Research Moderator: Shizuko Sei, MD – National Cancer Institute Altaf Mohammed, PhD – National Cancer Institute Mark Miller, PhD – National Cancer Institute
|
5:05-5:15 p.m. EDT
|
Conclusions Leisha Emens, MD, PhD – Ankyra Therapeutics, SITC President Philip Castle, PhD, MPH – National Cancer Institute
|